세계의 세포 사이토메트리 시장 : 업계 동향 및 예측 - 세포 사이토미터 유형별, 기업 규모별, 지역별, 주요 기업

GLOBAL CELL CYTOMETRY MARKET: OVERVIEW

As per Roots Analysis, the global cell cytometry market is estimated to grow from USD 1.82 billion in the current year to USD 5.26 billion by 2035, at a CAGR of 10.1% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Cell Cytometer

• High Throughput Flow Cytometers
• Image Cytometers

Company Size

• Very Small
• Small
• Mid-Sized
• Large
• Very Large

Geographical Regions

• North America (US, Canada, Mexico)
• Europe (France, Germany, Italy, Spain, UK, Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, Australia, Russia, Thailand, Malaysia, Indonesia, Rest of Asia Pacific)
• Middle East and North Africa (Iran, Saudi Arabia and Egypt)
• Latin America (Brazil, Argentina, Rest of Latin America)

GLOBAL CELL CYTOMETRY MARKET: GROWTH AND TRENDS

Cell cytometry is an analytical technique used for the analysis and characterization of cells. Recently, this technique has gained significant traction within the healthcare and pharmaceutical industries, particularly for biomarker identification and for assessing the relationship between pharmacodynamics and pharmacokinetics. Additionally, cell cytometers play a crucial role in evaluating the effects of targeted therapies on the immune system. Modern cell cytometers enable detailed characterization of immune cell populations and their responses to various diseases, making them highly versatile tools for analyzing biological samples. With the global rise in chronic diseases, the demand for advanced bioanalytical techniques like cell cytometry is continuously increasing.

Given the wide applications of cell cytometry ranging from basic research to drug discovery and clinical diagnostics, it has become an invaluable tool for unraveling immune responses, tracking disease progression, and understanding cellular mechanisms. As a result, many industry players are focusing on research efforts to develop advanced cell cytometry technologies featuring high-throughput capabilities, multiplexing options and enhanced data analysis tools.

GLOBAL CELL CYTOMETRY MARKET: KEY INSIGHTS

The report delves into the current state of global cell cytometry market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Presently, over 220 cell cytometers are currently available for use across wide range of clinical studies and research applications; majority of these have been developed by companies based in the US.
• The market landscape features a variety of cell cytometers that make use of multiple detection mechanisms and color channels to count and sort cells.
• Majority (91%) of the high throughput flow cytometers that use less than 10 color channels have been developed by players headquartered in the US.

• In pursuit of building a competitive edge, stakeholders are making an active effort to incorporate advanced features in their respective portfolio of cytometers and comply with evolving industry benchmarks.
• With the growing adoption of cytometers, several industry players have signed multiple agreements for high throughput flow cytometers and image cytometers.
• The maximum number of partnerships were reported in the previous year; most of these deals were distribution agreements and acquisitions.
• Notably, all acquisitions in the industry have been undertaken by players headquartered in North America (75%); majority of these deals are focused on the expansion of product portfolio.
• Having realized the opportunity in the cell cytometry segment, several investors have collectively invested multi-million dollars to aid the development of cytometers with advanced features.
• Majority (~90%) of the amount raised via venture rounds was reported through venture series B and D; of these, most of the instances reported were of venture series B funding round.
• Both industry and non-industry players have participated in various global events to discuss the research outcomes, affiliated challenges as well as opportunities in the cell cytometry industry.
• 75% of the webinars in this domain have been organized in the last couple of years; of these, majority were organized by Labroots.
• More than 1,500 patents related to cell cytometers have been granted / filed by academia and industry stakeholders in the last five years; majority of these were patent applications.
• The market is expected to grow at a CAGR of 10.1%; the projected market opportunity is likely to be well distributed across different types of cytometers; North America is likely to capture majority of the current market share.

Example Players in the Cell Cytometry Market

• Agilent
• Beckton Dickinson
• Beckman Coulter Life Sciences
• Bio-Rad
• Chemometec
• Milkotronic
• PerkinElmer
• Sartorius
• Sony Biotechnology
• Thermo Fisher Scientific
• Union Biometrica

GLOBAL CELL CYTOMETRY MARKET: KEY SEGMENTS

High Throughput Cell Cytometers Segment Occupies the Largest Share of the Cell Cytometry Market

Based on the type of cell cytometers, the market is segmented into high throughput cell cytometers and image cytometers. At present, high throughput cell cytometers segment holds the maximum (~60%) share of the global cell cytometry market. However, due to the rising demand for high resolution analytical tools for the sub-cellular visualization of cell morphology, image cytometers segment is expected to grow at a higher CAGR during the forecast period.

By Company Size, Very Large Companies is the Fastest Growing Segment of the Global Cell Cytometry Market

Based on the company size, the market is segmented into very small, small, mid-size, large, and very large companies. Currently, very large segment captures the highest proportion (~40%) of the cell cytometry market. Further, this segment is likely to grow at a relatively higher CAGR due to the ongoing efforts of large companies in this domain, in addition to their strong R&D capabilities, extensive distribution networks and established brand reputation.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, North America (~60%) dominates the cell cytometry market and accounts for the largest revenue share. However, the market in Asia-Pacific is expected to grow at a higher CAGR of 14% during the forecast period.

GLOBAL CELL CYTOMETRY MARKET

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global cell cytometry market, focusing on key market segments, including [A] type of cell cytometer, [B] company size and [C] key geographical regions.
• High Throughput Flow Cytometers Market Landscape: A comprehensive evaluation of high throughput flow cytometers, considering various parameters, such as [A] type of high throughput flow cytometer, [B] throughput rate (wells per minute), [C] detection rate, [D] type of plate format(s), [E] number of color channels, [F] number of laser channels, [G] number of detection channels, [H] sample volume (in µl), [I] type of detection mechanism(s) and [J] application(s). Additionally, the section presents a comprehensive evaluation of high throughput flow cytometer developers, based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading players.
• Product Competitiveness Analysis: An insightful competitive analysis of high throughput flow cytometers, examining factors, such as [A] developer power and [B] product competitiveness.
• Image Cytometers Market Landscape: A comprehensive evaluation of image cytometers, considering various parameters, such as [A] type of image cytometer, [B] processing time, [C] type of plate format(s), [D] output format(s), [E] sample volume and [F] application(s). Additionally, a comprehensive evaluation of image cytometer developers, based on [A] year of establishment, [B] company size, [C] location of headquarters and [E] leading players (in terms of number of products being offered).
• Product Competitiveness Analysis: An insightful competitive analysis of image cytometers, examining factors, such as [A] developer power and [B] product competitiveness.
• Company Profiles: In-depth profiles of companies engaged in the development / commercialization of cell cytometers, focusing on [A] company overview and [B] recent developments and an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] most active players (in terms of the number of partnerships signed) and [D] geographical distribution of partnership activity.
• Recent Developments: A detailed analysis of recent developments / trends related to global cell cytometry domain, providing key insights on the funding activity in this domain, based on several relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested (USD Million), [D] most active players and [E] most active investors. Additionally, the section presents a detailed evaluation of the global events attended by the participants, based on several relevant parameters, such as [A] year of event, [B] event platform, [C] type of event, [D] most active organizers and [E] most active organizations.
• Patent Analysis: An in-depth analysis of patents filed / granted for cell cytometry, based on various relevant parameters, such as [A] publication year, [B] geography, [C] CPC symbols, [D] emerging focus areas, [E] type of applicant, [F] leading industry players and [G] patent valuation analysis.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Cell Cytometry
  • 3.2.1. Flow Cytometry
    • 3.2.1.1. High Throughput Flow Cytometry
  • 3.2.2 Image Cytometry
• 3.3. Advantages and Limitations of Cell Cytometry
• 3.4. Prevalent Trends Related to Cell Cytometry
  • 3.4.1. Key Historical Trends
  • 3.4.2. Geographical Activity

4. HIGH THROUGHPUT FLOW CYTOMETERS: MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. High Throughput Flow Cytometers: Overall Market Landscape
  • 4.2.1. Analysis by Type of High Throughput Flow Cytometer
  • 4.2.2. Analysis by Throughput Rate
  • 4.2.3. Analysis by Detection Rate
  • 4.2.4. Analysis by Type of Plate Format(s)
  • 4.2.5. Analysis by Number of Color Channels
  • 4.2.6. Analysis by Number of Detection Channels
  • 4.2.7. Analysis by Number of Laser Channels
  • 4.2.8. Analysis by Sample Volume
  • 4.2.9. Analysis by Type of Detection Mechanism(s)
  • 4.2.10. Analysis by Application(s)
• 4.3. High Throughput Flow Cytometers: Developer Landscape
  • 4.3.1. Analysis by Year of Establishment
  • 4.3.2. Analysis by Company Size
  • 4.3.3. Analysis by Location of Headquarters
  • 4.3.4. Most Active Players: Analysis by Number of Products Offered

5. PRODUCT COMPETITIVENESS ANALYSIS: HIGH THROUGHPUT FLOW CYTOMETERS

• 5.1. Chapter Overview
• 5.2. Assumptions / Key Parameters
• 5.3. Methodology
• 5.4. Product Competitiveness Analysis
  • 5.4.1. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in North America
  • 5.4.2. Product Competitiveness Analysis: High Throughput Flow Cytometers offered by Developers based in Europe and Asia-Pacific

6. IMAGE CYTOMETERS: MARKET LANDSCAPE

• 6.1. Chapter Overview
• 6.2. Image Cytometers: Overall Market Landscape
  • 6.2.1. Analysis by Type of Image Cytometer
  • 6.2.2. Analysis by Processing Time
  • 6.2.3. Analysis by Type of Plate Format(s)
  • 6.2.4. Analysis by Output Format(s)
  • 6.2.5. Analysis by Sample Volume
  • 6.2.6. Analysis by Application(s)
• 6.3. Image Cytometers: Developer Landscape
  • 6.3.1. Analysis by Year of Establishment
  • 6.3.2. Analysis by Company Size
  • 6.3.3. Analysis by Location of Headquarters
  • 6.3.4. Most Active Players: Analysis by Number of Products Offered

7. PRODUCT COMPETITIVENESS ANALYSIS: IMAGE CYTOMETERS

• 7.1. Chapter Overview
• 7.2. Assumptions / Key Parameters
• 7.3. Methodology
• 7.4. Product Competitiveness Analysis
  • 7.4.1. Product Competitiveness Analysis: Image Cytometers offered by Developers based in North America
  • 7.4.2. Product Competitiveness Analysis: Image Cytometers offered by Developers based in Europe and Asia-Pacific

8. GLOBAL CELL CYTOMETRY: COMPANY PROFILES

• 8.1. Chapter Overview
• 8.2. Agilent
  • 8.2.1. Company Overview
  • 8.2.2. Recent Developments and Future Outlook
• 8.3. Beckman Coulter Life Sciences
  • 8.3.1. Company Overview
  • 8.3.2. Recent Developments and Future Outlook
• 8.4. Becton Dickinson
  • 8.4.1. Company Overview
  • 8.4.2. Recent Developments and Future Outlook
• 8.5. Bio-Rad
  • 8.5.1. Company Overview
  • 8.5.2. Recent Developments and Future Outlook
• 8.6. Chemometec
  • 8.6.1. Company Overview
  • 8.6.2. Recent Developments and Future Outlook
• 8.7. Milkotronic
  • 8.7.1. Company Overview
  • 8.7.2. Recent Developments and Future Outlook
• 8.8. Nexcelom Bioscience
  • 8.8.1. Company Overview
  • 8.8.2. Recent Developments and Future Outlook
• 8.9. Sartorius
  • 8.9.1. Company Overview
  • 8.9.2. Recent Developments and Future Outlook
• 8.10. Sony Biotechnology
  • 8.10.1. Company Overview
  • 8.10.2. Recent Developments and Future Outlook
• 8.11. ThermoFisher Scientific
  • 8.11.1. Company Overview
  • 8.11.2. Recent Developments and Future Outlook
• 8.12. Union Biometrica
  • 8.12.1. Company Overview
  • 8.12.2. Recent Developments and Future Outlook

9. GLOBAL CELL CYTOMETYRY: PARTNERSHIPS AND COLLABORATIONS

• 9.1. Chapter Overview
• 9.2. Partnership Models
• 9.3. List of Partnerships and Collaborations
  • 9.3.1. Analysis by Year of Partnership
  • 9.3.2. Analysis by Type of Partnership
  • 9.3.3. Most Active Players: Analysis by Number of Partnerships
  • 9.3.4. Regional Analysis
  • 9.3.5. Intercontinental and Intracontinental Agreements

10. RECENT DEVELOPMENTS

• 10.1. Chapter Overview
• 10.2. Global Cell Cytometry: Funding and Investment Analysis
  • 10.2.1. Types of Funding
  • 10.2.2. Analysis by Year of Investment
  • 10.2.3. Analysis by Type of Funding
  • 10.2.4. Analysis by Amount Invested
  • 10.2.5. Most Active Players: Analysis by Number of Funding Instances
  • 10.2.6. Most Active Players: Analysis by Amount Raised
  • 10.2.7. Most Active Investors: Analysis by Number of Funding Instances
• 10.3. Global Cell Cytometry: Global Event Analysis
  • 10.3.1. Analysis by Year of Event
  • 10.3.2. Analysis by Event Platform
  • 10.3.3. Analysis by Type of Event
  • 10.3.4. Analysis by Geography
  • 10.3.5. Most Active Event Organizers: Analysis by Number of Events
  • 10.3.6. Most Active Organizations: Analysis by Number of Participants
• 10.4. Concluding Remarks

11. PATENT ANALYSIS

• 11.1. Chapter Overview
• 11.2. Scope and Methodology
  • 11.2.1. Analysis by Type of Patent
  • 11.2.2. Analysis by Patent Publication Year
  • 11.2.3. Analysis by Annual Number of Granted Patents and Patent Applications
  • 11.2.4. Analysis by Geographical Location
  • 11.2.5. Analysis by CPC Symbols
  • 11.2.6. Analysis by Type of Organization
  • 11.2.7. Leading Industry Players: Analysis by Number of Patents
  • 11.2.8. Leading Non-Industry Players: Analysis by Number of Patents
  • 11.2.9. Leading Individual Assignees: Analysis by Number of Patents
• 11.3. Cell Cytometry: Patent Benchmarking Analysis
  • 11.3.1. Analysis by Patent Characteristics
• 11.4. Cell Cytometry: Patent Valuation Analysis
• 11.5. Leading Patents by Number of Citations

12. MARKET FORECAST

• 12.1. Chapter Overview
• 12.2. Key Assumptions and Methodology
• 12.3. Global Cell Cytometry Market, Till 2035
  • 12.3.1. Global Cell Cytometry Market: Distribution by Type of Cell Cytometer
    • 12.3.1.1. Cell Cytometry Market for High Throughput Flow Cytometers, Till 2035
    • 12.3.1.2. Cell Cytometry Market for Image Cytometers, Till 2035
  • 12.3.2. Global Cell Cytometry Market: Distribution by Company Size
    • 12.3.2.1. Cell Cytometry Market for Very Small Companies, Till 2035
    • 12.3.2.2. Cell Cytometry Market for Small Companies, Till 2035
    • 12.3.2.3. Cell Cytometry Market for Mid-sized Companies, Till 2035
    • 12.3.2.4. Cell Cytometry Market for Large Companies, Till 2035
    • 12.3.2.5. Cell Cytometry Market for Very Large Companies, Till 2035
  • 12.3.3. Global Cell Cytometry Market: Distribution by Key Geographical Regions
    • 12.3.3.1. Cell Cytometry Market in North America, Till 2035
    • 12.3.3.2. Cell Cytometry Market in Europe, Till 2035
    • 12.3.3.3. Cell Cytometry Market in Asia-Pacific, Till 2035
    • 12.3.3.4. Cell Cytometry Market in Rest of the World, Till 2035

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS